Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Berstein

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Mutation Research|September 23, 1996
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patientsL M Berstein, E V Bakhidze, T P Evtushenko, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 25, 1999
Macrophages, estrogen and the microenvironment of breast cancerG Mor, W Yue, R J Santen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 17, 1999
Study of tobacco smoke influence on content of estrogens and DNA flow cytometry data in uterine tissue of rats of different ageL M Berstein, E V Tsyrlina, V B Gamajunova, et al.
Voprosy Onkologii|February 24, 2004
[Comparative characteristics of hormonal status in patients with receptor-negative cancers of the breast and of the endometrium]L M Berstein, E V Tsyrlina, I G Kovalenko, et al.
Archiv Fur Geschwulstforschung|January 1, 1988
Preliminary evidence on metabolic rehabilitation of cancer patientsV M Dilman, L M Berstein, T P Yevtushenko, et al.
Voprosy Onkologii|November 22, 2018
[The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy]A V Novik, S A Protsenko, I A Baldueva, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2004
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancerL M Berstein, J O Kvatchevskaya, T E Poroshina, et al.
Cancer Letters|June 7, 2000
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free womenE S Kuligina, A V Togo, E N Suspitsin, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2001
CYP19 gene polymorphism in endometrial cancer patientsL M Berstein, E N Imyanitov, E N Suspitsin, et al.
Journal of Cancer Research and Clinical Oncology|April 16, 2003
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancerL M Berstein, A E Tchernobrovkina, V B Gamajunova, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Mutation Research|September 23, 1996
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patientsL M Berstein, E V Bakhidze, T P Evtushenko, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 25, 1999
Macrophages, estrogen and the microenvironment of breast cancerG Mor, W Yue, R J Santen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 17, 1999
Study of tobacco smoke influence on content of estrogens and DNA flow cytometry data in uterine tissue of rats of different ageL M Berstein, E V Tsyrlina, V B Gamajunova, et al.
Voprosy Onkologii|February 24, 2004
[Comparative characteristics of hormonal status in patients with receptor-negative cancers of the breast and of the endometrium]L M Berstein, E V Tsyrlina, I G Kovalenko, et al.
Archiv Fur Geschwulstforschung|January 1, 1988
Preliminary evidence on metabolic rehabilitation of cancer patientsV M Dilman, L M Berstein, T P Yevtushenko, et al.
Voprosy Onkologii|November 22, 2018
[The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy]A V Novik, S A Protsenko, I A Baldueva, et al.
Journal of Cancer Research and Clinical Oncology|August 24, 2004
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancerL M Berstein, J O Kvatchevskaya, T E Poroshina, et al.
Cancer Letters|June 7, 2000
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free womenE S Kuligina, A V Togo, E N Suspitsin, et al.
Journal of Cancer Research and Clinical Oncology|February 24, 2001
CYP19 gene polymorphism in endometrial cancer patientsL M Berstein, E N Imyanitov, E N Suspitsin, et al.
Journal of Cancer Research and Clinical Oncology|April 16, 2003
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancerL M Berstein, A E Tchernobrovkina, V B Gamajunova, et al.
Pageof 9